Detailansicht

Wissensnetz

Person

Ugur Sahin (1965-)

Arzt

Name	Ugur Sahin
Zeit	1965- (Lebensdaten)
Ort	Iskenderun (Geburtsort) Köln (Wirkungsort) Mainz (Wirkungsort) Deutschland Türkei
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Immunologe Onkologe Hochschullehrer Unternehmer Vorstandsvorsitzender
Variante	Uğur Şahin
Familie	Özlem Türeci (Ehefrau)
Beziehung	BioNTech SE (Mitbegründer und -eigentümer sowie Vorstandsvorsitzender) (2008-) Universitätsmedizin Mainz (Leitendende Positionen; ab 2006 Professor für experimentelle Onkologie) (2001-) Universität zu Köln. Medizinische Einrichtungen (Arzt für Innere Medizin und Hämatologie/Onkologie) Deutsche Akademie der Naturforscher Leopoldina (Mitglied, Matrikelnummer 7961) (2021-)
Themengebiet	Personen zu Medizin, Tiermedizin Personen zu Betriebswirtschaftslehre Personen zu Gewerbe allgemein, Industrie, Handwerk
Quelle	Wikipedia: https://de.wikipedia.org/w/index.php?title=U%C4%9Fur_%C5%9Eahin&oldid=222954434 (Stand: 17.06.2022)
Datensatztyp	Person
GND-Nummer	1160959498
Datensatz-ID	1160959498
Beteiligt an alle anzeigen Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer Identification of structural variations from whole genome sequencing of cancer patients Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA Iodine-124 PET quantifcation of organ-specifc delivery and expression of NIS-encoding RNA NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells Projekt Lightspeed : der Weg zum BioNTech-Impfstoff - und zu einer Medizin von morgen Projekt Lightspeed : Der Weg zum BioNTech-Impfstoff - und zu einer Medizin von morgen COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy More than a virus : How COVID 19 infected education in Turkey? Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma Actively personalized vaccination trial for newly diagnosed glioblastoma Induction of immunosuppressive functions and NF-κB by FLIP in monocytes Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET Challenges towards the realization of individualized cancer vaccines Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide HLA and proteasome expression body map Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population Comparison of subdermal and perforator delay techniques on a rat flap model Trace elements in blood samples of smoker and nonsmoker active pulmonary tuberculosis patients from Jamshoro, Pakistan An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells HLA typing from RNA-Seq sequence reads Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols rapmad: Robust analysis of peptide microarray data Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2 Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors Bispezifische monoklonale Antikörper zur Aktivierung von Zytostatikavorstufen an Tumorzellen : ein neues immuntherapeutisches Modell The vaccine

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Ugur Sahin (1965-)

Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer

Identification of structural variations from whole genome sequencing of cancer patients

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma

Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA

Iodine-124 PET quantifcation of organ-specifc delivery and expression of NIS-encoding RNA

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells

Projekt Lightspeed : der Weg zum BioNTech-Impfstoff - und zu einer Medizin von morgen

Projekt Lightspeed : Der Weg zum BioNTech-Impfstoff - und zu einer Medizin von morgen

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

More than a virus : How COVID 19 infected education in Turkey?

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

Actively personalized vaccination trial for newly diagnosed glioblastoma

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue

In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET

Challenges towards the realization of individualized cancer vaccines

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide

HLA and proteasome expression body map

Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

Comparison of subdermal and perforator delay techniques on a rat flap model

Trace elements in blood samples of smoker and nonsmoker active pulmonary tuberculosis patients from Jamshoro, Pakistan

An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®

Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice

Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry

Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens

Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells

HLA typing from RNA-Seq sequence reads

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols

rapmad: Robust analysis of peptide microarray data

Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2

Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors

Bispezifische monoklonale Antikörper zur Aktivierung von Zytostatikavorstufen an Tumorzellen : ein neues immuntherapeutisches Modell

The vaccine